Adaptive RadioTherapy for OroPharynx Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Adaptive RadioTherapy for OroPharynx Cancer — Stella

Home/Oropharynx Cancer/

View on ClinicalTrials.gov

Recruiting

Back to Oropharynx Cancer trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

Australia

Austin Health, Melbourne

Canada

Centre Hospitalier de l'Université de Montréal, Montreal, Quebec

Key details

Phase

Safety & dosing

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Collaborators

Austin Health

Enrollment target

~120 participants

Started

July 2021

Primary completion

December 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated December 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.